The insulin delivery devices market accounted to USD 11.0 billion in 2016 growing at a CAGR of 8.8% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Global Insulin Delivery Devices Market – Market Definition:
The insulin delivery devices are the devices that are used for delivering insulin. There are numerous types of devices which are used for delivering insulin such as syringes, pens, jet injectors, insulin pumps among others.
Global Insulin Delivery Devices Market – Major Market Drivers and Restraints:
- Increasing number of diabetics patients
- Growing prevalence of obesity leading to diabetes
- Portability of insulin pumps and easy use
- Technological advancements in the insulin devices
Global Insulin Delivery Devices Market – Market Segmentation:
By product type the insulin delivery devices market is segmented into insulin syringes, insulin pens, insulin pumps, pen needles, insulin syringes and insulin injectors. Insulin pens are further segmented into reusable and disposable. Insulin pumps is further segmented into external/tethered and patch. Also Pen needles are segmented into standard and safety.
On the basis of End User the market is segmented into homecare, hospitals, clinics and others.
On the basis of geography, insulin delivery devices market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, andBrazil among others. In 2017, North America is expected to dominate the market.
Global Insulin Delivery Devices Market – Competitive Analysis:
Insulin delivery devices market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of insulin delivery devices market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors:
Some of the major players operating in insulin delivery devices market are Novo Nordisk A/S, Ypsomed Holding AG, Animas Corporation, Tandem Diabetes Care, Inc., Medtronic plc, Sanofi, Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott Laboratories, F. Hoffmann-La Roche Ltd., B. Braun Melsungen AG, among others.
Global Insulin Delivery Devices Market – Research Methodology:
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request analyst call or drop down your enquiry.
Demand Side Primary Contributors: Doctors, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.